Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.

Yamada-Fujiwara M, Miyamura K, Fujiwara T, Tohmiya Y, Endo K, Onishi Y, Ishizawa K, Kameoka J, Ito M, Harigae H.

Tohoku J Exp Med. 2012 May;227(1):31-7.

2.

[HSC transplantation-associated intestinal thrombotic microangiopathy: clinical pathological features, diagnosis criteria and treatment].

Dong LJ, Xie DH, Lu DP, Chen H, Gao ZY, Chen YH, Wu T, Han W, Zhang XH, Zhao YL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Apr;14(2):327-31. Chinese.

PMID:
16638208
3.

Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.

Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, Imagama S, Kanie T, Murata M, Taji H, Suzuki R, Morishita Y, Kodera Y.

Bone Marrow Transplant. 2004 Jun;33(11):1143-50.

PMID:
15077133
4.

Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.

de Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, Bay JO, Neven B, Moussi J, Simon L, Xhaard A, Resche-Riggon M, O'Meara A, Fremeaux-Bacchi V, Veyradier A, Socié G, Coppo P, de Latour RP.

Transplantation. 2015 Sep;99(9):1953-9. doi: 10.1097/TP.0000000000000601.

PMID:
25651309
5.

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.

Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J, Wallace G, Chima RS, Paff Z, Laskin BL.

Blood. 2014 Jul 24;124(4):645-53. doi: 10.1182/blood-2014-03-564997. Epub 2014 May 29.

6.

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.

Labrador J, López-Corral L, López-Godino O, Vázquez L, Cabrero-Calvo M, Pérez-López R, Díez-Campelo M, Sánchez-Guijo F, Pérez-López E, Guerrero C, Alberca I, Del Cañizo MC, Pérez-Simón JA, González-Porras JR, Caballero D.

Bone Marrow Transplant. 2014 May;49(5):684-90. doi: 10.1038/bmt.2014.17. Epub 2014 Feb 24.

PMID:
24566710
7.

Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.

Fujiwara H, Maeda Y, Sando Y, Nakamura M, Tani K, Ishikawa T, Nishimori H, Matsuoka K, Fujii N, Kondo E, Tanimoto M.

Transfusion. 2016 Apr;56(4):886-92. doi: 10.1111/trf.13437. Epub 2015 Dec 29.

PMID:
26711692
8.

Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.

García-Martín P, Alarcón-Payer C, López-Fernández E, Moratalla L, Romero A, Sainz J, Ríos R, Jurado M.

Ann Pharmacother. 2015 Sep;49(9):986-94. doi: 10.1177/1060028015593369. Epub 2015 Jul 9.

PMID:
26160968
9.

Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.

El-Bietar J, Warren M, Dandoy C, Myers KC, Lane A, Wallace G, Davies SM, Jodele S.

Biol Blood Marrow Transplant. 2015 Nov;21(11):1994-2001. doi: 10.1016/j.bbmt.2015.06.016. Epub 2015 Jul 4.

10.

Severe diarrhea following bone marrow transplantation is not always caused by GVHD.

De Petris G, Corominas Cishek A, Dzeletovic I.

Gastroenterology. 2014 Jun;146(7):e5-6. doi: 10.1053/j.gastro.2014.01.008. Epub 2014 Apr 28. No abstract available.

PMID:
24786559
11.

Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Mii A, Shimizu A, Kaneko T, Fujita E, Fukui M, Fujino T, Utsumi K, Yamaguchi H, Tajika K, Tsuchiya S, Iino Y, Katayama Y, Fukuda Y.

Pathol Int. 2011 Sep;61(9):518-27. doi: 10.1111/j.1440-1827.2011.02704.x. Epub 2011 Jul 12.

PMID:
21884301
12.

Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis.

Shayani S, Palmer J, Stiller T, Liu X, Thomas SH, Khuu T, Parker PM, Khaled SK, Forman SJ, Nakamura R.

Biol Blood Marrow Transplant. 2013 Feb;19(2):298-304. doi: 10.1016/j.bbmt.2012.10.006. Epub 2012 Oct 15.

13.

Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.

Kennedy GA, Kearey N, Bleakley S, Butler J, Mudie K, Durrant S.

Bone Marrow Transplant. 2010 Apr;45(4):699-704. doi: 10.1038/bmt.2009.233. Epub 2009 Sep 21.

PMID:
19767787
14.
15.

Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Avanzini MA, Maccario R, Locatelli F, Giebel S, Santos CD, Bernardo ME, Pagliara D, Montagna D, Longo S, Amendola G, Marconi M.

Exp Hematol. 2006 Oct;34(10):1429-34.

PMID:
16982336
16.

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.

Willems E, Baron F, Seidel L, Frère P, Fillet G, Beguin Y.

Bone Marrow Transplant. 2010 Apr;45(4):689-93. doi: 10.1038/bmt.2009.230. Epub 2009 Aug 31.

PMID:
19718063
17.

Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation.

Narimatsu H, Kami M, Hara S, Matsumura T, Miyakoshi S, Kusumi E, Kakugawa Y, Kishi Y, Murashige N, Yuji K, Masuoka K, Yoneyama A, Wake A, Morinaga S, Kanda Y, Taniguchi S.

Bone Marrow Transplant. 2005 Sep;36(6):517-23.

PMID:
16025150
18.
19.

Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim Y, Kim DW, Lee JW, Min WS, Kim CC.

Bone Marrow Transplant. 2008 May;41(9):813-20. doi: 10.1038/sj.bmt.1705976. Epub 2008 Jan 21.

PMID:
18209725
20.

Successful treatment of refractory acute GVHD complicated by severe intestinal transplant-associated thrombotic microangiopathy using recombinant thrombomodulin.

Inoue Y, Kosugi S, Miura I, Hatta Y, Takeuchi J.

Thromb Res. 2011 Jun;127(6):603-4. doi: 10.1016/j.thromres.2010.12.023. Epub 2011 Jan 22. No abstract available.

PMID:
21262525

Supplemental Content

Support Center